The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor

Blood

Volumn 87, Issue 3, 1996, Pages 1013-1021

  Kroner, Philip A ^a   Foster, Paul A ^b   Fahs, Scot A ^b   Montgomery, Robert R ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 8; HISTIDINE; VON WILLEBRAND FACTOR;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VON WILLEBRAND DISEASE;

EID: 0030040896     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1013.bloodjournal8731013     Document Type: Article

References (45)

1. Montgomery RR, Coller BS: von Willebrand Disease, in Colraan RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 134
2. Sadler JE, Davie EW: Hemophilia A, hemophilia B, and von Willebrand disease, in Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds): The Molecular Basis of Blood Diseases. Philadelphia, PA, Saunders, 1994, p 657
3. Tuddenham EGD, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kernoff PBA: Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol 52:259, 1982
4. Koedam JA, Meijers JC, Sixma JJ, Bouma BN: Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82:1236, 1988
5. Fay PJ, Coumans JV, Walker FJ: von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 266:2172, 1991
6. Hill-Eubanks DC, Lollar P: von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 265:17854, 1990
7. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS: A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 262:8443, 1987
8. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D: Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 70:1679, 1987
9. Mazurier C: von Willebrand disease masquerading as haemophilia A. Thromb Haemost 67:391, 1992
10. Montgomery RR, Hathaway WE, Johnson J, Jacobson L, Muntean W: A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood 60:201, 1982
11. Simone JV, Vanderheiden J, Abildgaard CF: A semiautomatic one-stage factor VIII assay. J Lab Clin Med 69:706, 1967
12. Pool JG, Robinson N: Assay of plasma antihemophilic globulin (AHG). Br J Haematol 5:17, 1959
13. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D: New variant of von Willebrand disease with defective binding to factor VIII. Blood 74:1591, 1989
14. Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M: A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75:20. 1990
15. Sadler JE: A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thromb Haemost 71:520, 1994
16. Kroner PA, Friedman KD, Fahs SA, Scott JP, Montgomery RR: Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 266:19146, 1991
17. Perez-Casal M, Daly M, Peake I, Batlle J: A case of recessive type 2N von Willebrand's disease due to Arg 53 Trp substitution. Am J Hematol 48:140, 1995
18. Gaucher C, Jorieux S, Mercier B, Oufkir D, Mazurier C: The "Normandy" variant of von Willebrand disease: Characterization of a point mutation in the von Willebrand factor gene. Blood 77:1937, 1991
19. Gaucher C, Mercier B, Jorieux S, Oufkir D. Mazurier C: Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease. Br J Haematol 78:506, 1991
20. Cachens PM, Nichols WC, Ginsburg D: Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 266:13499, 1991
21. Wise RJ, Ewenstein BM, Gorlin J, Narins SC, Jesson M, Handin RI: Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation. Hum Genet 91:367, 1993
22. Peerlinck K, Eikenboom JC, Ploos van Amstel HK, Sangtawesin W, Arnout J, Reitsma PH, Vermylen J, Briet E: A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by GIn in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele Br J Haematol 80:358, 1992
23. Siguret V, Lavergne JM, Cherel G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Pietu G: A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD. Hum Genet 93:95, 1994
24. Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Pietu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D: Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression. Thromb Haemost 70:691, 1993
25. Jorieux S, Tuley EA, Gaucher C, Mazurier C, Sadler JE: The mutation Arg (53) → Tip causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor. Blood 79:563, 1992
26. Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler JE, Mazurier C: Expression of von Willebrand factor "Normandy": An autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 88:6377, 1991
27. Bonthron D, Orr EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH: Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res 14:7125, 1986
28. Kunkel TA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367, 1987
29. Kroner PA, Foster PA, Fahs SA, Montgomery RR: Persistence of pro-vWf, an inherited cause of reduced factor VIII binding, and its comparison with other factor VIII binding vWf mutants. Thromb Haemost 69:1212, 1993 (abstr)
30. Feigner PL, Gadck TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM. Danielson M: Lipofection: A highly efficient, lipie-mediated DNA transfection procedure. Proc Natl Acad Sci USA 84:7413, 1987
31. Montgomery RR, Kunicki TJ, Glode LM: Use of monoclonal antibody to increase the sensitivity and specificity of precipitating immunoassays and cell surface binding immunoassays. Methods Enzymol 121:702, 1986
32. Raines G, Aumann H, Sykes S, Street A: Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel. Thromb Res 60:201, 1990
33. Marti T, Rosselet SJ, Titani K, Walsh KA: Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 26.8099, 1987
34. Jorieux S, Gaucher C, Pietu G, Cherel G, Meyer D, Mazurier C: Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: Interest for the localization of the factor VIII binding domain. Br J Haematol 87:113, 1994
35. Sadler JE, Ginsburg D: A database of polymorphisms in the von Willebrand factor gene and pseudogene. For the Consortium on von Willebrand Factor Mutations and Polymorphisms and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 69:185, 1993
36. Belgrader P, Maquat LE: Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping. Mol Cell Biol 14:6326, 1994
37. Muhlrad D, Parker R: Premature translational termination triggers mRNA decapping. Nature 370:578, 1994
38. Eikenboom JC, Ploos van Amstel HK, Reitsma PH, Briet E: Mutations in severe, type III von Willebrand's disease in the Dutch population: Candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA. Thromb Haemost 68:448, 1992
39. Foster PA, Fulcher CA, Houghten RA, Zimmerman TS: An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 263:5230, 1988
40. Leyte A, Van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, van Mourik JA: Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 266:740, 1991
41. Ginsburg D, Sadler JE: von Willebrand disease: A database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 69:177, 1993
42. Lopez-Fernandez MF, Blanco-Lopez MJ, Castineira MP, Batlle J: Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 40:20, 1992
43. LiCata VJ, Ackers GK: Long-range, small magnitude nonadditivity of mutational effects in proteins. Biochemistry 34:3133, 1995
44. Lavergne JM, Piao YC, Ferreira V, Kerbiriou-Nabias D, Bahnak BR, Meyer D: Primary structure of the factor VIII binding domain of human, porcine and rabbit von Willebrand factor. Biochem Biophys Res Commun 194:1019, 1993
45. Rick ME, Krizek DM: Identification of a molecular defect in a patient with von Willebrand's disease and defective binding of factor VIII Blood 84:59a, 1994 (abstr, suppl 1)